• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增殖型糖尿病性视网膜病变患者的急诊表现:随访及与依从性相关的因素。

PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance.

机构信息

Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida.

出版信息

Retina. 2020 May;40(5):928-935. doi: 10.1097/IAE.0000000000002481.

DOI:10.1097/IAE.0000000000002481
PMID:30897069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6739198/
Abstract

PURPOSE

To determine the rate of follow-up after emergent encounters for proliferative diabetic retinopathy and to identify patient or visit characteristics associated with follow-up compliance.

METHODS

A retrospective cohort study of patients presenting to an ophthalmic emergency department with active proliferative diabetic retinopathy between May 2014 and December 2016 was conducted. Demographic data and encounter data were gathered for each emergency department visit. Compliance with follow-up was defined as a completed clinic visit as scheduled after the emergency encounter.

RESULTS

A total of 590 emergency department encounters were included. The overall follow-up rate was 61.9%. Married patients and those with Public Health Trust insurance had increased odds of compliance (odds ratio [OR]: 1.507, P = 0.04; OR: 2.749, P < 0.0001). Patients with Medicaid had reduced odds (OR: 0.543, P = 0.004). Patients with longer emergency department encounters and longer intervals to follow-up had reduced odds (OR: 0.948, P = 0.001; OR of 0.941, P < 0.0001). The other characteristics were not significantly associated with follow-up compliance.

CONCLUSION

Patients who present emergently with active proliferative diabetic retinopathy are at high risk of following up noncompliance. Characteristics with significant effects on the odds of follow-up compliance include specific insurance payer, marriage status, length of visit, and interval to follow-up.

摘要

目的

确定增殖性糖尿病视网膜病变急诊后随访的比率,并确定与随访依从性相关的患者或就诊特征。

方法

对 2014 年 5 月至 2016 年 12 月期间因活动性增殖性糖尿病视网膜病变就诊眼科急诊的患者进行回顾性队列研究。收集每个急诊就诊的人口统计学数据和就诊数据。将随访依从性定义为在急诊就诊后按计划完成诊所就诊。

结果

共纳入 590 次急诊就诊。总的随访率为 61.9%。已婚患者和拥有公共卫生信托保险的患者更有可能遵守(优势比[OR]:1.507,P = 0.04;OR:2.749,P < 0.0001)。拥有医疗补助的患者可能性降低(OR:0.543,P = 0.004)。急诊就诊时间较长和随访时间间隔较长的患者,可能性降低(OR:0.948,P = 0.001;OR 为 0.941,P < 0.0001)。其他特征与随访依从性无显著相关性。

结论

因活动性增殖性糖尿病视网膜病变急诊就诊的患者不遵守随访的风险很高。对随访依从性几率有显著影响的特征包括特定的保险支付者、婚姻状况、就诊时间和随访间隔。

相似文献

1
PATIENTS PRESENTING EMERGENTLY WITH PROLIFERATIVE DIABETIC RETINOPATHY: Follow-up and Factors Associated With Compliance.增殖型糖尿病性视网膜病变患者的急诊表现:随访及与依从性相关的因素。
Retina. 2020 May;40(5):928-935. doi: 10.1097/IAE.0000000000002481.
2
FOLLOW-UP ADHERENCE IN PATIENTS WITH NONPROLIFERATIVE DIABETIC RETINOPATHY PRESENTING TO AN OPHTHALMIC EMERGENCY DEPARTMENT.非增殖性糖尿病视网膜病变患者就诊于眼科急诊后的随访依从性。
Retina. 2021 Jun 1;41(6):1293-1301. doi: 10.1097/IAE.0000000000003037.
3
Factors Associated with Non-compliance for Diabetic Retinopathy Follow-up in an Urban Safety-Net Hospital.城市安全网医院中糖尿病视网膜病变随访不依从的相关因素
Ophthalmic Epidemiol. 2018 Oct-Dec;25(5-6):443-450. doi: 10.1080/09286586.2018.1504311. Epub 2018 Aug 6.
4
Patients' Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use.在一个由公共资金资助的县级诊所,糖尿病视网膜病变筛查后患者对推荐的后续眼部护理的依从性以及与后续眼部护理使用相关的因素。
JAMA Ophthalmol. 2016 Nov 1;134(11):1221-1228. doi: 10.1001/jamaophthalmol.2016.3081.
5
Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan.沿着增殖性致盲途径评估糖尿病视网膜病变的进展及治疗效果:对台湾糖尿病视网膜病变筛查的启示
Diabet Med. 2003 Sep;20(9):727-33. doi: 10.1046/j.1464-5491.2003.01019.x.
6
Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional study.坦桑尼亚糖尿病视网膜病变患者筛查后随访不佳的原因:一项横断面研究
BMC Ophthalmol. 2016 Jul 19;16:115. doi: 10.1186/s12886-016-0288-z.
7
Follow-up compliance after emergency department evaluation.急诊科评估后的随访依从性。
Ann Emerg Med. 1993 Mar;22(3):560-7. doi: 10.1016/s0196-0644(05)81942-0.
8
Association of Patient and Visit Characteristics With Rate and Timing of Urologic Procedures for Patients Discharged From the Emergency Department With Renal Colic.患者和就诊特征与因肾绞痛从急诊科出院的患者接受泌尿科治疗的比例和时间的关联。
JAMA Netw Open. 2019 Dec 2;2(12):e1916454. doi: 10.1001/jamanetworkopen.2019.16454.
9
Improving specialty care follow-up after an ED visit using a unique referral system.利用独特的转诊系统改善 ED 就诊后的专科医疗随访。
Am J Emerg Med. 2013 Oct;31(10):1495-500. doi: 10.1016/j.ajem.2013.08.007. Epub 2013 Sep 10.
10
Diabetic eye screening with variable screening intervals based on individual risk factors is safe and effective in ophthalmic practice.根据个体危险因素制定可变的筛查间隔进行糖尿病眼病筛查在眼科实践中是安全有效的。
Acta Ophthalmol. 2020 Jun;98(4):343-346. doi: 10.1111/aos.14425. Epub 2020 Mar 25.

引用本文的文献

1
Factors associated with lost to follow-up and delayed follow-up in patients with choroidal nevus.脉络膜痣患者失访和随访延迟的相关因素。
Eye (Lond). 2025 Jun 19. doi: 10.1038/s41433-025-03889-w.
2
Exploring patient and health care provider perspectives on barriers to diabetic retinopathy screening in public health facilities in North India.探索印度北部公共卫生机构中患者及医疗服务提供者对糖尿病视网膜病变筛查障碍的看法。
Sci Rep. 2025 Mar 10;15(1):8251. doi: 10.1038/s41598-025-92795-y.
3
Loss to Follow-Up in Patients With Proliferative Diabetic Retinopathy or Diabetic Macular Edema.增殖性糖尿病视网膜病变或糖尿病黄斑水肿患者的失访情况。
JAMA Netw Open. 2024 Dec 2;7(12):e2450942. doi: 10.1001/jamanetworkopen.2024.50942.
4
Socioeconomic Disparities and Emergency Department Visits for Diabetic Retinopathy in California.加利福尼亚州糖尿病视网膜病变的社会经济差异与急诊就诊情况
J Vitreoretin Dis. 2024 Feb 26;8(3):293-298. doi: 10.1177/24741264241234132. eCollection 2024 May-Jun.
5
The Relationship Between Health Insurance Status and Diabetic Retinopathy Progression.健康保险状况与糖尿病视网膜病变进展之间的关系。
Ophthalmol Sci. 2023 Dec 22;4(3):100458. doi: 10.1016/j.xops.2023.100458. eCollection 2024 May-Jun.
6
Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy.开发和验证预测增殖性糖尿病视网膜病变进展的模型。
Ophthalmol Sci. 2023 Feb 1;3(2):100276. doi: 10.1016/j.xops.2023.100276. eCollection 2023 Jun.
7
Social Determinants of Health and Impact on Screening, Prevalence, and Management of Diabetic Retinopathy in Adults: A Narrative Review.成人糖尿病视网膜病变筛查、患病率及管理中的健康社会决定因素:一项叙述性综述
J Clin Med. 2022 Nov 30;11(23):7120. doi: 10.3390/jcm11237120.
8
Temporal Trends in the Treatment of Proliferative Diabetic Retinopathy: An AAO IRIS® Registry Analysis.增殖性糖尿病视网膜病变治疗的时间趋势:美国眼科学会IRIS®注册研究分析
Ophthalmol Sci. 2021 Jun 28;1(3):100037. doi: 10.1016/j.xops.2021.100037. eCollection 2021 Sep.
9
Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.广角 OCT 血管造影评估全视网膜光凝治疗前后增生性糖尿病视网膜病变中的视网膜无灌注。
Am J Ophthalmol. 2020 May;213:177-185. doi: 10.1016/j.ajo.2020.01.024. Epub 2020 Mar 13.

本文引用的文献

1
Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内雷珠单抗治疗增生性糖尿病视网膜病变的 5 年疗效比较:一项随机临床试验。
JAMA Ophthalmol. 2018 Oct 1;136(10):1138-1148. doi: 10.1001/jamaophthalmol.2018.3255.
2
Loss to Follow-Up in Patients with Proliferative Diabetic Retinopathy after Panretinal Photocoagulation or Intravitreal Anti-VEGF Injections.增生性糖尿病视网膜病变患者行全视网膜光凝或玻璃体内抗 VEGF 注射后的失访分析。
Ophthalmology. 2018 Sep;125(9):1386-1392. doi: 10.1016/j.ophtha.2018.02.034. Epub 2018 Mar 29.
3
Trends in the Contribution of Emergency Departments to the Provision of Hospital-Associated Health Care in the USA.美国急诊科对医院相关医疗服务提供的贡献趋势。
Int J Health Serv. 2018 Apr;48(2):267-288. doi: 10.1177/0020731417734498. Epub 2017 Oct 17.
4
Large Disparities in Receipt of Glaucoma Care between Enrollees in Medicaid and Those with Commercial Health Insurance.医疗补助计划参保者与商业健康保险参保者在青光眼护理接受情况上存在巨大差异。
Ophthalmology. 2017 Oct;124(10):1442-1448. doi: 10.1016/j.ophtha.2017.05.003. Epub 2017 Jun 2.
5
US Spending on Personal Health Care and Public Health, 1996-2013.1996 - 2013年美国个人医疗保健和公共卫生支出
JAMA. 2016 Dec 27;316(24):2627-2646. doi: 10.1001/jama.2016.16885.
6
Diabetes 2030: Insights from Yesterday, Today, and Future Trends.《2030年糖尿病:从过去、现在到未来趋势的洞察》
Popul Health Manag. 2017 Feb;20(1):6-12. doi: 10.1089/pop.2015.0181. Epub 2016 Apr 28.
7
Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.2型糖尿病非裔美国人增殖性糖尿病视网膜病变的危险因素
Ophthalmic Epidemiol. 2016;23(2):88-93. doi: 10.3109/09286586.2015.1119287. Epub 2016 Mar 7.
8
Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.全视网膜光凝与玻璃体内注射雷珠单抗治疗增殖性糖尿病视网膜病变的随机临床试验
JAMA. 2015 Nov 24;314(20):2137-2146. doi: 10.1001/jama.2015.15217.
9
Injury type and emergency department management of orthopaedic patients influences follow-up rates.骨科患者的损伤类型和急诊科处理方式会影响随访率。
J Bone Joint Surg Am. 2014 Oct 1;96(19):1650-8. doi: 10.2106/JBJS.M.01481.
10
When to use the Bonferroni correction.何时使用邦费罗尼校正。
Ophthalmic Physiol Opt. 2014 Sep;34(5):502-8. doi: 10.1111/opo.12131. Epub 2014 Apr 2.